New Guidelines Recommend Shorter All-Oral TB Treatment Regimens
The latest clinical practice guidelines advocate for four- and six-month all-oral regimens for eligible children and adults with drug-susceptible or drug-resistant tuberculosis.
The latest clinical practice guidelines advocate for four- and six-month all-oral regimens for eligible children and adults with drug-susceptible or drug-resistant tuberculosis.
The latest clinical practice guidelines advocate for four- and six-month all-oral regimens for eligible children and adults with drug-susceptible or drug-resistant tuberculosis.
Read MoreResearchers found the treatment also reduced the spread of colds to family members.
Read MoreAlso, researchers link traffic-related air pollution to asthmatic patients developing COPD.
Read MoreA study found that young people who vape have reduced exercise capacity similar to that of young smokers.
Read MoreResearch predicts that vaping—in addition to smoking and air pollution—will increase the burden of COPD in Western Europe by 2050, while home NIV is expected to reduce mortality from COPD exacerbations.
Read MorePeople who start smoking before age 18 are more likely to experience respiratory symptoms, such as wheezing and phlegm, in their 20s.
Read MoreA new study finds individuals with higher genetic risk for COPD show lower lung function starting in childhood.
Read MoreResearchers have shown it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease using the patients’ own lung cells.
Read MoreA small patient trial also suggests CPAP may be more effective than a weight-loss drug in tackling clogged arteries.
Read MoreOn World No Tobacco Day, May 31, international lung health groups are raising concerns over Big Tobacco’s impact on environmental health and ultimately lung health.
Read MoreUpdated clinical practice guidelines from ATS/ERS cover idiopathic pulmonary fibrosis and address progressive pulmonary fibrosis in patients with interstitial lung diseases other than IPF.
Read MoreThe ATS and ERS have updated their pulmonary function tests technical standard series to address the uncertainty around the interpretation of tests.
Read MoreGlobal lung health organizations from the US, Europe, Australia, and Asia have established the first World Bronchiectasis Day for July 1, 2022, to raise awareness of bronchiectasis and its increased prevalence in many countries.
Read MoreHealthcare organizations are concerned respiratory medication delivery technology will now be used to more effectively deliver tobacco and nicotine.
Read MoreGlaxoSmithKline will provide updates on research across its respiratory portfolio at the European Respiratory Society International Congress.
Read More